Pharmaceutical company IBSA Pharmaceutici Italia has published its third sustainability report.
The report details the objectives, performances and activities relating to the environmental, economic and social sustainability of the company.
Within the report, an growth in industrial production was recognised, the transition towards non-fossil fuels has accelerated and the renewable component in the energy mix supplied by industrial partners has increased.
Director of HA-Derma, the exclusive distributor of IBSA in the UK and Ireland, Iveta Vinklerova, said, “It’s a privilege to be representing a company like IBSA who are not only leading the way in the hyaluronic acid innovation, but despite the global success the company has been experiencing in the recent years and not blind to the effects this can have on the environment and are already taking actions towards a more sustainable business.”
A copy of the report is available upon request by the company.
